September 1, 1996Open Access

Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.

JHJérôme HonnoratUniversité Claude Bernard Lyon 1 JAJ. C. AntoineCentre Hospitalier Universitaire de Saint-Étienne EDEdmund DerringtonUniversité Claude Bernard Lyon 1

Key Points

Key points are not available for this paper at this time.

Abstract

The detection of anti-CV2 antibodies in patients with neurological disorders should be considered as an indication of the presence of an occult cancer.

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Honnorat et al. (Sun,) studied this question.

synapsesocial.com/papers/69de064157c7c8340a558388 https://doi.org/https://doi.org/10.1136/jnnp.61.3.270

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1In situ demonstration of mature oligodendrocytes and their processes: An immunocytochemical study with a new monoclonal antibody, Rip1989 · 249 citations
2Anti-Hu-Associated Paraneoplastic Encephalomyelitis/Sensory Neuronopathy A Clinical Study of 71 Patients1992 · 822 citations
3Neuronal antinuclear antibody in sensory neuronopathy from lung cancer1985 · 370 citations
4Paraneoplastic cerebellar degeneration1992 · 174 citations
5Immunoperoxidase Labeling of Rat Brain Sections with Sera from Patients with Paraneoplastic Cerebellar Degeneration and Systemic Neoplasia1988 · 46 citations

Perguntar à IA

Bookmark

View Full Paper